Race/ethnicity, disability, and medication adherence among medicare beneficiaries with heart failure

Journal of General Internal Medicine

Volumn 29, Issue 4, 2014, Pages 602-607

  Zhang, Yuting ^a   Baik, Seo Hyon ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

disability; heart failure; Medicare; medication adherence; racial disparity

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; AMERICAN INDIAN; ARTICLE; ASIAN; CAUCASIAN; CONTROLLED STUDY; DISABILITY; ETHNICITY; FEMALE; HEALTH STATUS; HEART FAILURE; HISPANIC; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MEDICATION COMPLIANCE; MIDDLE AGED; NEGRO; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRESCRIPTION; RACE DIFFERENCE; VERY ELDERLY; AFRICAN AMERICAN; ANCESTRY GROUP; ASIAN AMERICAN; DISABLED PERSON; ECONOMICS; ETHNIC GROUP; ETHNOLOGY; INCOME; RANDOMIZED CONTROLLED TRIAL; TRENDS; UNITED STATES;

AFRICAN AMERICANS; AGED; ASIAN AMERICANS; CONTINENTAL POPULATION GROUPS; DISABLED PERSONS; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEART FAILURE; HISPANIC AMERICANS; HUMANS; INCOME; INDIANS, NORTH AMERICAN; MALE; MEDICARE PART D; MEDICATION ADHERENCE; UNITED STATES;

EID: 84898600875     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-013-2692-x     Document Type: Article

References (24)

1. American Heart Association. Heart and Stroke Statistical Update. Dallas: American Heart Association 2006; 2006.
2. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119(14):1977-2016. doi: 10.1161/circulationaha.109.192064.
3. Wu J-R, Moser DK, Chung ML, Lennie TA. Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure. J Card Fail. 2008;14(3):203-10.
4. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80 %. BMJ. 2003;326(7404):1419.
5. Newby LK, Allen LaPointe NM, Chen AY, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006;113(2):203-12. doi: 10.1161/circulationaha.105.505636.
6. Choudhry NK, Avorn J, Glynn RJ, et al. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011;365(22):2088-97. doi: 10.1056/NEJMsa1107913.
7. Stroupe KT, Teal EY, Weiner M, Gradus-Pizlo I, Brater DC, Murray MD. Health care and medication costs and use among older adults with heart failure. Am J Med. 2004;116(7):443-50.
8. Zhang Y, Wu S, Fendrick AM, Baicker K. Variation in medication adherence in heart failure. JAMA Intern Med. 2013:1-2. doi: 10.1001/jamainternmed.2013. 2509
9. Neuman P, Strollo MK, Guterman S, et al. Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors. Health Aff. 2007;26(5):w630-43. doi: 10.1377/hlthaff.26.5.w630.
10. Zhang Y, Lave JR, Donohue JM, Fischer MA, Chernew ME, Newhouse JP. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Med Care. 2010;48(5):409-17. doi: 10.1097/MLR.0b013e3181d68978.
11. Institute of Medicine. Geographic Variation in Health Care Spending and Promotion of High-Value Care - Interim Report. IOM. 2013. http://www.iom.edu/ Reports/2013/Geographic-Variation-in-Health-Care-Spending-and-Promotion-of-High- Care-Value-Interim-Report.aspx. Accessed October 21, 2013.
12. Bonito A, Bann C, Eicheldinger C, Carpenter L. Creation of new race-ethnicity codes and Socioeconomic Status (SES) indicators for medicare beneficiaries. Final Report. Sub-Task 2. (Prepared by RTI International for the Centers for Medicare and Medicaid Services through an interagency agreement with the Agency for Healthcare Research and Policy, under Contract No. 500-00-0024, Task No. 21). Agency for Healthcare Research and Quality, Rockville, MD. 2008. http://www.ahrq.gov/qual/medicareindicators/medicareindicators.pdf. Accessed October 21, 2013.
13. Zhang Y, Baik SH, Chang CC, Kaplan CM, Lave JR. Disability, race/ethnicity, and medication adherence among Medicare myocardial infarction survivors. Am Heart J. 2012;164(3):425-33 e4. doi: 10.1016/j.ahj.2012.05.021.
14. Kaiser Family Foundation. Low-income assistance under the Medicare drug benefit. Menlo Park, CA, USA. 2009. http://kaiserfamilyfoundation.files. wordpress.com/2013/01/7327-05.pdf. Accessed October 21, 2013.
15. Zhang Y, Baik SH, Fendrick AM, Baicker K. Comparing local and regional variation in health care spending. N Engl J Med. 2012;367(18):1724-31. doi: 10.1056/NEJMsa1203980.
16. Centers for Medicare & Medicaid Services. 2011 Model diagnosis and model softweare - RxHCC model software. Centers for Medicare & Medicaid Services, Baltimore, MD, USA. 2011. https://www.cms.gov/Medicare/Health-Plans/ MedicareAdvtgSpecRateStats/Risk-adjustment.html. Accessed October 21, 2013.
17. Davis AM, Vinci LM, Okwuosa TM, Chase AR, Huang ES. Cardiovascular health disparities: a systematic review of health care interventions. Med Care Res Rev. 2007;64(5 Suppl):29S-100S.
18. Lewey J, Shrank WH, Bowry AD, Kilabuk E, Brennan TA, Choudhry NK. Gender and racial disparities in adherence to statin therapy: a meta-analysis. Am Heart J. 2013;165(5):665-78 e1. doi: 10.1016/j.ahj.2013.02.011.
19. Bagchi AD, Esposito D, Kim M, Verdier J, Bencio D. Utilization of, and adherence to, drug therapy among Medicaid beneficiaries with congestive heart failure. Clin Ther. 2007;29(8):1771-83.
20. Zhang Y, Gellad WF, Zhou L, Lin Y-J, Lave JR. Access to and use of $4 Generic Programs in Medicare. J Gen Intern Med. 2012;27(10):1251-7.
21. Wijeysundera HC, Machado M, Farahati F, et al. Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. JAMA. 2010;303(18):1841-7.
22. Zhang Y, Donohue JM, Lave JR, O'Donnell G, Newhouse JP. The effect of Medicare Part D on drug and medical spending. N Engl J Med. 2009;361(1):52-61. doi: 10.1056/NEJMsa0807998.
23. Hsu J, Price M, Huang J, et al. Unintended consequences of caps on Medicare drug benefits. N Engl J Med. 2006;354(22):2349-59.
24. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555-67.